- Vienna '18
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: P.Jegadeesan INDIA
Back to previous
To evaluate the safety and efficacy of using periocular depot steroid instead if topical drops following cataract surgery.
Private practice in south India.
25 patients were given periocular depot medrol at the end of cataract surgery. 0.5 to 0.7 ml were given in the superior sub conjunctival space.Patients were reviewed weekly for 4 weeks.
One patient had an increase in IOP of more than 5 mm above baseline. One patient needed supplemental topical steroids after 2 weeks. 4 patients developed conjunctival necrosis and needed excision of the depot steroid.
Peri Ocular depot medrol has significant morbidity. It has to be used with caution after routine cataract surgery.